The role of chemokines in transplant immunology

Transplantation Reviews

Volumn 17, Issue 2, 2003, Pages 87-95

  Reinders, Marlies E J ^a,b   Laning, Joseph C ^a,b   Paul, Leendert C ^a,b   Briscoe, David M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CYCLOSPORIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ALLOGRAFT; CELL INFILTRATION; CHRONIC GRAFT REJECTION; CLINICAL OBSERVATION; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LEUKOCYTE; NONHUMAN; RECIPIENT; REPERFUSION INJURY; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

EID: 0037528962     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(03)00002-8     Document Type: Article

References (91)

1. Sayegh MH, Turka LA: The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998, 338:1813
2. Carpenter CB: Long-term failure of renal transplants: Adding insult to injury. Kidney Int Suppl 1995, 50:S40
3. Li XC, Strom TB, Turka LA, et al: T cell death and transplantation tolerance. Immunity 2001, 14:407
4. Sayegh MH: Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1999, 56:1967
5. Waldmann H, Cobbold S: Regulating the immune response to transplants. A role for CD4+ regulatory cells? Immunity 2001, 14:399
6. Denton MD, Davis SF, Baum MA, et al: The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr Transplant 2000, 4:252
7. Krensky AM, Weiss A, Crabtree G, et al: T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 1990, 322:510
8. Krieger NR, Yin DP, Fathman CG: CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996, 184:2013
9. Dengler TJ, Pober JS: Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000, 164:5146
10. Ma W, Pober JS: Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 1998, 161:2158
11. Briscoe DM, Alexander SI, Lichtman AH: Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol 1998, 10:525
12. Denton MD, Geehan C, Alexander SI, et al: Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4+ T cell alloactivation. J Exp Med 1999, 190:555
13. Szeto WY, Krasinskas AM, Kreisel D, et al: Depletion of recipient CD8- T cells does not alter the development of cardiac allograft vasculopathy. J Heart Lung Transplant 2001, 20:219
14. Briscoe DM: Recent insights into the role(s) of the endothelium in allorecognition. Graft 1999, 2:261
15. Pober JS, Orosz CG, Rose ML, et al: Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996, 61:343
16. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration; The multistep paradigm. Cell 1994, 76:301
17. Briscoe DM, Ganz P, Alexander SI, et al: The problem of chronic rejection: influence of leukocyte-endothelial interactions. Kidney Int 1997, 51:S22
18. Cotran RS, Briscoe DM: Endothelial cells in inflammation. In: Kelley NN, Harris ED, Ruddy S, eds. Textbook of Rheumatology. Philadelphia, PA, Saunders, 1997, pp 183-198
19. Melter M, McMahon G, Fang J, et al: Current understanding of chemokine involvement in allograft transplantation. Pediatr Transplant 1999, 3:10
20. Nelson PJ, Krensky AM: Chemokines, chemokine receptors, and allograft rejection. Immunity 2001, 14:377
21. Baggiolini M: Chemokines in pathology and medicine. J Intern Med 2001, 250:91
22. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998, 392:565
23. Moser B, Loetscher P: Lymphocyte traffic control by chemokines. Nat Immunol 2001, 2:123
24. Zlotnik A, Yoshie O: Chemokines: A new classification system and their role in immunity. Immunity 2000, 12:121
25. Murdoch C, Finn A: Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000, 95:3032
26. Campbell JJ, Hedrick J, Zlotnik A, et al: Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998, 279:381
27. Lloyd AR, Oppenheim JJ, Kelvin DJ, et al: Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J Immunol 1996, 156:932
28. Campbell JJ, Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000, 12:336
29. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718
30. Hancock WW, Gao W, Csizmadia V, et al: Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001, 193:975
31. Hancock WW, Lu B, Gao W, et al: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000, 192:1515
32. Miura M, Morita K, Kobayashi H, et al: Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 2001, 167:3494
33. Kapoor A, Morita K, Engeman TM, et al: Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells. Transplantation 2000, 69:1147
34. Kapoor A, Morita K, Engeman TM, et al: Intragraft expression of chemokine gene occurs early during acute rejection of allogeneic cardiac grafts. Transplant Proc 2000, 32:793
35. Watarai Y, Koga S, Paolone DR, et al: Intraallograft chemokine RNA and protein during rejection of MHC- matched/ multiple minor histocompatibility-disparate skin grafts. J Immunol 2000, 164:6027
36. Gao W, Topham PS, King JA, et al: Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000, 105:35
37. Pattison J, Nelson PJ, Huie P, et al: RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994, 343:209
38. Belperio JA, Keane MP, Arenberg DA, et al: CXC chemokines in angiogenesis. J Leukoc Biol 2000, 68:1
39. Keane MP, Arenberg DA, Lynch JP 3rd, et al: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997, 159:1437
40. Tanaka H, Sukhova GK, Libby P: Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 1994, 14:734
41. Gjertson DW: Impact of delayed graft function and acute rejection on kidney graft survival. Clin Transpl 2000, 467
42. Takada M, Nadeau KC, Shaw GD, et al: The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997, 99:2682
43. Takada. M, Chandraker A, Nadeau KC, et al: The role of the B7 costimulatory pathway in experimental cold ischemia/ reperfusion injury. J Clin Invest 1997, 100:1199
44. Burne MJ, Daniels F, El Ghandour A, et al: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001, 108:1283
45. Tullius SG, Tilney NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995, 59:313
46. Tilney NL, Nadeau K: Inflammatory mediators, cells and their products in acute host alloresponsiveness. Ann Transplant 1996, 1:5
47. Wang CY, Naka Y, Liao H, et al: Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. Circ Res 1998, 82:762
48. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A 1995, 92:8729
49. Hancock WH, Whitley WD, Tullius SG, et al: Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993, 56:643
50. Hancock WW: Chemokines and transplant immunobiology. J Am Soc Nephrol 2002, 13:821
51. Briscoe DM, Cotran RS: Role of leukocyte-endothelial cell adhesion molecules in renal inflammation: In vitro and in vivo studies. Kidney Int 1993, 44, Suppl 42:S27-S34.
52. Takada M, Nadeau KC, Shaw GD, et al: Early cellular and molecular changes in ischemia/reperfusion injury. Inhibition by a selectin antagonist, P-selectin glycoprotein ligand-1. Transplant Proc 1997, 29:1324
53. Han KT, Sharar SR, Phillips ML, et al: Sialyl Lewis(x) oligosaccharide reduces ischemia-reperfusion injury in the rabbit ear. J Immunol 1995, 155:4011
54. Buerke M, Weyrich AS, Zheng Z, et al: Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994, 93:1140
55. Rabb H, Mendiola CC, Dietz J, et al: Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol 1994, 267:F1052
56. Kelly KJ, Williams WW Jr, Colvin RB, et al: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996, 97:1056
57. de Groot-Kruseman HA, Baan CC, Loonen EH, et al: Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection. J Heart Lung Transplant 2001, 20:503
58. Adams DH, Hubscher S, Fear J, et al: Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. Transplantation 1996, 61:817
59. Oz MC, Liao H, Naka. Y, et al: Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. Circulation 1995, 92(9 Suppl),II428
60. Pesonen EJ, Hockerstedt K, Makisalo H, et al: Transhepatic neutrophil and monocyte activation during clinical liver transplantation. Transplantation 2000, 69:1458
61. Flach R, Speidel N, Flohe S, et al: Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 1998, 10:445
62. Lukacs NW, Kunkel SL, Burdick MD, et al: The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3. Am J Pathol 1993, 143:1179
63. Christensen PJ, Rolfe MW, Standiford TJ, et al: Characterization of the production of monocyte chemoattractant protein-1 and IL-8 in an allogeneic immune response. J Immunol 1993, 151:1205
64. Ebert LM, McColl SR: Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation. J Immunol 2001, 166:4870
65. Gao W, Faia KL, Csizmadia V, et al: Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001, 72:1199
66. Horuk R, Clayberger C, Krensky AM, et al: A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem 2001, 276:4199
67. Hancock WW, Gao W, Faia KL, et al: Chemokines and their receptors in allograft rejection. Curr Opin Immunol 2000, 12:511
68. Haskell CA, Hancock WW, Salant DJ, et al: Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 2001, 108:679
69. Kondo T, Novick AC, Toma H, et al: Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 1996, 61:1750
70. Segerer S, Cui Y, Eitner F, et al: Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001, 37:518
71. Robertson H, Morley AR, Talbot D, et al: Renal allograft rejection: Beta-chemokine involvement in the development of tubulitis. Transplantation 2000, 69:684
72. Melter M, Exeni A, Reinders ME, et al: Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001, 104:2558
73. Zhao DX, Hu Y, Miller G, et al: Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: Association with cardiac allograft vasculopathy and acute rejection. J Immunol 2002, 169(3), 1556
74. Azuma H, Tilney NL: Chronic graft rejection. Curr Opin Immunol 1994, 6:770
75. Knechtle S: Chronic rejection: The clinical problem. Graft 1998, 1S11:47
76. Libby P, Pober JS: Chronic rejection. Immunity 2001, 14:387
77. Libby P, Tanaka H: The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. Clin Transplant 1994, 8:313
78. Cotran RS: Inflammation and repair. In: Cotran RS, Kumar V, Robbins SL, eds. Pathologic Basis of Disease. Philadelphia, PA, Saunders, 1994, pp 51-92
79. Russell ME, Adams DH, Wyner LR, et al: Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci U S A 1993, 90:6086
80. Azuma H, Nadeau KC, Ishibashi M, et al: Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 1995, 60:1577
81. Gullestad L, Simonsen S, Ueland T, et al: Possible role of proinflammatory cytokines in heart allograft coronary artery disease. Am J Cardiol 1999, 84:999
82. Belperio JA, Keane MP, Burdick MD, et al: Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 2001, 108:547
83. Nagano H, Mitchell RN, Taylor MK, et al: Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997, 100:550
84. Tellides G, Tereb DA, Kirkiles-Smith NC, et al: Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403:207
85. Wu L, Gerard NP, Wyatt R, et al: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384:179
86. Palacios E, Digilio L, McClure HM, et al: Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol 1998, 8:943
87. Blanpain C, Lee B, Tackoen M, et al: Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood 2000, 96:1638
88. Fischereder M, Luckow B, Hocher B, et al: CC chemokine receptor 5 and renal-transplant survival. Lancet 2001, 357: 1758
89. Abdi R, Tran TB, Sahagun-Ruiz A, et al: Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002, 13:754
90. Schroppel B, Fischereder M, Lin M, et al: Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients. J Clin Immunol 2002, 22:381
91. Schroppel B, Fischereder M, Ashkar P, et al: The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. Am J Transplant 2002, 2:640